CXCL13 and rheumatoid arthritis: found that CXCL13 promoted the expression of vascular endothelial growth factor (VEGF) in EPC via activation of PLC and MEK, with concomitant upregulated activator protein-1 (AP-1) signaling pathway, therefore contributing to EPC homing and angiogenesis during RA progression (76).